Brokerages Set Agilon Health, Inc. (NYSE:AGL) PT at $97.70

Agilon Health, Inc. (NYSE:AGL) has been assigned an average recommendation of “Hold” from the fourteen research firms that are presently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $97.70.

Several analysts have recently commented on the company. Wells Fargo & Company restated an “overweight” rating and set a $146.00 target price (up from $141.00) on shares of Agilon Health in a report on Tuesday, August 11th. Benchmark reiterated a “buy” rating and set a $140.00 price target (up from $95.00) on shares of Agilon Health in a research report on Thursday, August 6th. Robert W. Baird set a $116.00 price objective on shares of Agilon Health in a report on Thursday, August 6th. Barclays set a $111.00 price objective on shares of Agilon Health and gave the company an “equal weight” rating in a research report on Thursday, August 6th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agilon Health in a research note on Monday, August 24th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Allworth Financial LP bought a new position in shares of Agilon Health during the second quarter worth about $114,000. Proficio Capital Partners LLC bought a new stake in Agilon Health in the 2nd quarter valued at approximately $210,000. The Manufacturers Life Insurance Company acquired a new position in Agilon Health during the 2nd quarter worth approximately $355,000. Integrated Wealth Concepts LLC acquired a new position in Agilon Health during the 2nd quarter worth approximately $384,000. Finally, Corient Private Wealth LP bought a new position in shares of Agilon Health during the 2nd quarter worth approximately $406,000.

Agilon Health Stock Down 0.2%

AGL stock opened at $89.59 on Friday. Agilon Health has a 52-week low of $7.48 and a 52-week high of $133.04. The company’s 50 day simple moving average is $99.78 and its 200-day simple moving average is $69.49. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.08 and a quick ratio of 1.08. The firm has a market capitalization of $1.50 billion, a P/E ratio of -6.28 and a beta of 3.02.

Agilon Health (NYSE:AGL) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. The firm had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. As a group, equities research analysts anticipate that Agilon Health will post -2.9 EPS for the current year.

About Agilon Health

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company focuses primarily on patients enrolled in Medicare Advantage plans and works with physician groups to coordinate care, improve outcomes and manage healthcare costs.

Agilon provides physicians with technology, analytics, operational support and clinical resources designed to help them manage the health of defined patient populations.